Eagle Pharmaceuticals
EGRX
#10665
Rank
ยฃ2.45 M
Marketcap
ยฃ0.19
Share price
0.00%
Change (1 day)
-89.47%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: ยฃ2.45 Million

As of June 2026 Eagle Pharmaceuticals has a market cap of ยฃ2.45 Million. This makes Eagle Pharmaceuticals the world's 10665th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ2.45 M-43.34%
2025ยฃ4.32 M-23.76%
2024ยฃ5.67 M-89.35%
2023ยฃ53.31 M-83.05%
2022ยฃ0.31 B-35.45%
2021ยฃ0.48 B9.43%
2020ยฃ0.44 B-28.71%
2019ยฃ0.62 B41.4%
2018ยฃ0.44 B-25.12%
2017ยฃ0.58 B-40.73%
2016ยฃ0.99 B6.36%
2015ยฃ0.93 B569.51%
2014ยฃ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ432.45 B 17,627,080.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ217.83 B 8,879,109.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ753.54 B 30,715,125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ142.97 B 5,827,865.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ87.01 B 3,546,563.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ79.32 B 3,233,245.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ30.07 B 1,225,784.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel